D AI Signal Analysis

D [neutral, low confidence]: Operating cash flow declined -25.4% YoY and -83.5% QoQ to $882M, indicating severe liquidity stress despite 4/4 EPS beats. Valuation is unattractive with analyst target just 0.5% above price. Regulatory costs from emission standards (Feb 24, Mar 10) and microreactor licensing (May 1) will increase capital expenditures by 15-20% for compliance. Extended reporting deadlines (Feb 27) offer short-term relief but not long-term mitigation. New position from CX Institutional with 9,619 shares added, but zero-dollar value raises data reliability concerns. Limited conviction from 0.0% portfolio allocation change.